White House Pauses NIH Grant Order After Congressional Pushback

Key points

• The White House is drafting an executive order to create an external committee with veto power over NIH grants, aiming to align funding with the president's political agenda.
• The proposal emerged after a contentious meeting where NIH Director Jay Bhattacharya refused President Trump's request to cut funding for Harvard University.
• Senate Appropriations Chair Susan Collins has actively opposed the plan, arguing it politicizes scientific research and threatens the passage of a December stopgap spending bill.
• The administration is currently backing off the initial order but may release a revised version after the midterm elections to avoid the appearance of 'political meddling with science.'
• The NIH manages $48 billion in congressionally appropriated funds, and the proposed board would include both NIH Director Jay Bhattacharya and OMB Director Russell Vought.

Background

This development follows a series of conflicts between the Trump administration and the NIH over the politicization of scientific research. In 2025, OMB Director Russell Vought attempted to freeze NIH grant-making, leading to a clash with NIH Director Jay Bhattacharya. Congress subsequently intervened to block Vought's plan to give political appointees control over federal health grants. Additionally, the American Association for Cancer Research (AACR) has warned that funding cuts and political interference could stall future cancer breakthroughs and delay the development of new therapies.

How outlets are covering it

The New York Times and The Bulwark emphasize the White House's attempt to exert direct control over NIH grants, framing it as a significant escalation in the administration's effort to redirect billions of dollars in research spending. Politico highlights the specific trigger for the order: Trump's desire to cut Harvard's funding after NIH Director Jay Bhattacharya refused to do so. Semafor, however, focuses on the administration's retreat, noting that the White House is backing off the initial plan due to pressure from Senate Appropriations Chair Susan Collins and concerns about the impact on the stopgap spending bill. While The Bulwark and The New York Times portray the order as a 'five-alarm fire' for medical research, Semafor suggests the administration may still pursue a less overtly political version after the midterm elections.

Why it matters

The proposed executive order would fundamentally alter the way the NIH, which manages $48 billion in annual funding, allocates grants. By introducing political appointees into the decision-making process, the order could undermine the scientific peer-review system that has governed NIH grants for decades. This could lead to the defunding of research that does not align with the administration's political priorities, potentially delaying the development of new treatments and therapies. Furthermore, the order could jeopardize the passage of a critical stopgap spending bill in December, which is essential for the continued operation of the NIH and other federal agencies.

What to watch

The White House is expected to revisit the issue after the midterm elections, potentially releasing a revised executive order that avoids the appearance of 'political meddling with science.' Congress will continue to monitor the situation and may take further action to block the implementation of the order. The NIH and other federal agencies will also be closely watching the developments, as the order could have significant implications for their funding and operations.